MAIN PAGE



NEW TARGETS FOR DIAGNOSIS AND IMMUNOTHERAPY OF CANCER AND OTHER DISEASES.

Genes, proteins, DNA, RNA, small molecules and more.

Bibliography:

DATA

TITLE	TYPE	YEAR	OTHER	ID
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response	review	2022		23
Oncometabolite d-2HG alters T cell metabolism to impair CD8+ T cell function	glioma	2022		22
Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells	colorectal	2022		21
V I S T A Emerges as a Promising Immunotherapy Target in Cancer	review	2022		20
PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer	breast	2022		15
A promising research direction for colorectal cancer immunotherapy: The regulatory mechanism of CCL5 in colorectal cancer	colorectal	2022		14
POU2AF2/C11orf53 functions as a coactivator of POU2F3 by maintaining chromatin accessibility and enhancer activity	lung	2022		13
Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3- and B7H4-dependent anti-tumor immunity in colorectal cancer	colorectal	2022		12
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer	lung	2022		11
Next-generation immuno-oncology agents: Current momentum shifts in cancer immunotherapy	review	2020		25
Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1	leukemia	2020		17
Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy	review	2019		24
Monoclonal Antibodies, Antibody-Drug Conjugates, and Bispecific Antibodies	review			16